Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
By LabPulse.com staff writers

August 20, 2019 -- Image analysis software developer Perspectum Diagnostics said its new partnership with pathology services provider ProPath will enable pharmaceutical companies to receive both pathology and imaging interpretation services for liver disease clinical trials from one contract research organization.

Both services will be available over a single cloud-based platform, according to Perspectum. The firm said the alliance will also support its initiative to develop a digital pathology package.

AI wins some -- and loses some -- in test against pathologists
A novel artificial intelligence (AI) algorithm outperformed pathologists in differentiating ductal carcinoma in situ from atypical hyperplasia, a job...
Fujifilm, Inspirata partner on digital pathology in U.K.
Fujifilm Medical Systems and digital pathology provider Inspirata have agreed on a new commercial partnership through which Fujifilm will supply and service...
Artificial intelligence takes root in pathology
Artificial intelligence -- the simulation of human intelligence processes by software -- is reaching commercial pathology labs and has begun to significantly...
With LabCorp's lead, Mount Sinai dives into digital pathology
LabCorp is working with the Mount Sinai healthcare system in New York City to build out digital pathology services, including the establishment of a center...
Smaller labs eye digital pathology options to improve workflow
As workloads increase in laboratory medicine, some pathology labs have considered harnessing new technologies to improve workflow and efficiency. One...

Copyright © 2019 LabPulse.com

Last Updated np 8/20/2019 10:12:51 AM